IREN Partners with Dell Technologies in 16 Billion AI Infrastructure Deal Vodafone Idea Share Price Hits Fresh 52Week High on Continued Subscriber Growth Rally Extends to Seventh Day EU Green Economy Doubles Output in Less Than a Decade as Solar Energy Surges XP Inc Files Form 6K With SEC as Part of Ongoing Regulatory Disclosure Trump Rejects Iran Counteroffer Prolonging Middle East Conflict and Energy Market Uncertainty Market Rises Broadly as Healthcare and Tech Lead Communication Services Lags NVCR Q1 2026 Earnings WiderThanExpected Loss Fails to Dampen Investor Sentiment PGEN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid Zero Revenue CRDF Q1 2026 Earnings WiderthanExpected Loss Reflects Ongoing RD Investments DLX Q1 2026 Earnings Strong EPS Beat Amidst Ongoing Strategic Transformation PRDO Q1 2026 Earnings Profit Beats Expectations as Company Delivers Strong EPS Surprise AIZ Q1 2026 Earnings Strong EPS Beat Driven by Underwriting Performance Big Tree Cloud Holdings DSY Gains 74 as Shares Test Resistance Near 214 KalVista Pharmaceuticals KALV Holds Steady Near Resistance as Investors Eye Key Catalysts One Stop Systems Inc OSS Rallies 313 as Bulls Eye Resistance at 1902 K2 Capital Acquisition Units KTWOU Hold Steady at 1011 as Market Awaits Catalyst DAQO New Energy DQ Edges Higher in Narrow Range as Solar Sector Eyes Key Levels AMTD Q4 2020 Earnings Massive EPS Beat Highlights Strong Operational Performance Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares 7 ANDG Q1 2026 Earnings Massive EPS Surprise of 834 Shatters Estimates Actuate Therapeutics Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss FENC Q1 2026 Earnings Unexpected Profitability Surprises Market Stock Edges Lower One Liberty Properties Inc OLP Q1 2026 Earnings EPS Beats Estimates on Solid Property Performance Fortis Healthcare Reports 442 Surge in Q4 PAT to 2712 Crore FY26 Revenue Climbs 17 Allegion ALLE Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Operational Challenges Translational Development Acquisition Corp Warrants TDACW Surge 784 as Bulls Test Resistance